Brinter is a Finnish-based company specialised in custom-built 3D bioprinters for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. The company aims to provide unlimited transplantable organs, customisable and patient-specific drugs.

At present, the company's bioprinter platform is being used for the basic research in tissue engineering and regenerative medicine. 3D bioprinting solutions can lay a short-cut route to discovering new drugs. Bioprinted models with different cell type and complex, native-like, physiological environment will eliminate the need for in vivo models in the drug discovery process.